Improve breast cancer survival through knowledge, behaviors, coordination

April 9, 2020
Although significant progress has been made in breast cancer care, challenges and opportunities remain in cancer survivorship. “There are a…
In the Journals

MRI may be superior to clinical assessment in detecting morphea activity

April 9, 2020
MRI may be more sensitive in detecting morphea disease activity than clinical assessment, according to a research letter. A cross-sectional analysis…
Meeting News

Oral difelikefalin may safely treat pruritus in patients with nondialysis- dependent CKD

April 9, 2020
Patients with both pruritus and chronic kidney disease stages 3 to 5 experienced reduced itch intensity at 12 weeks after treatment with oral…

Retired physicians join fight against COVID-19 — should they?

April 8, 2020
COVID-19 is stretching the capacity of health care systems across the United States. The American Academy of Family Physicians and AMA have provided…
In the Journals

Mycophenolate shows efficacy, tolerability in morphea

April 8, 2020
A retrospective analysis showed that patients with recalcitrant morphea benefited from mycophenolate therapy, with tolerable adverse events…

AMA: Science, not speculation, will defeat COVID-19

April 8, 2020
During an address to the National Press Club on Tuesday, AMA President Patrice A. Harris, MD, MA, highlighted the importance of using scientifically…
In the Journals

Hair removal in gender-affirming care not covered by most Medicaid, ACA policies

April 7, 2020
Medicaid and Affordable Care Act policies often do not cover permanent hair removal treatments for transgender patients, which could pose a barrier…
In the Journals

PPE-associated headaches increase among health care workers amid COVID-19

April 7, 2020
Prolonged use of personal protective equipment during the COVID-19 pandemic such as N95 masks and protective eyewear was shown to cause or exacerbate…
In the Journals

ACE inhibitors heighten risk of renal crisis in systemic sclerosis

April 7, 2020
Angiotensin-converting enzyme inhibitors in patients with systemic sclerosis and concomitant arterial hypertension demonstrate an independent risk…
In the Journals

Afamelanotide may reduce symptoms, phototoxic reactions in erythropoietic protoporphyria

April 6, 2020
Treatment with afamelanotide was associated with improved clinical outcomes and a good safety profile in patients with erythropoietic protoporphyria…

‘Unmasking COVID-19’: Healio to launch new podcast for front-line clinicians

April 6, 2020
Information about COVID-19 is evolving at a rapid pace. To help physicians stay informed of the latest developments, Healio is launching the…
In the Journals

Pemphigus relapse linked with PDAI score, anti-DSG antibody values

April 3, 2020
Initial score on the Pemphigus Disease Area Index and evolution of anti-desmoglein antibody values 3 months after an initial cycle of rituximab are…
Guest Commentary

Guest Commentary: Managing a private practice during the COVID-19 pandemic

April 3, 2020
In this Guest Commentary, Peter R. Honig, DO, a family physician with a private practice
In the Journals

More data needed for anxiety reduction in Mohs micrographic surgery

April 2, 2020
Personalized music may be a viable option for reducing perioperative anxiety in patients undergoing Mohs micrographic surgery, but more data are…
In the Journals

Dermatologists call for proactive safety guidelines during COVID-19 pandemic

April 1, 2020
Health care delivery is facing rapid changes and urgent issues in the wake of the COVID-19 outbreak, propelling the need for more proactive safety…

Q&A: COVID-19 disrupts 2020 census

April 1, 2020
The negative downstream effects of the COVID-19 pandemic may extend to the United States census, a business and economy expert told Healio Primary…
In the Journals

Melanoma incidence in men, women differs by age, anatomic site

March 31, 2020
Melanoma incidence rates differ between men and women by age and anatomic site in predominantly fair-skinned populations, according to a…
In the Journals

Certain medical devices with FDA priority review have higher recall rates

March 31, 2020
High-risk, or class 3, medical devices that underwent FDA priority review had higher recall rates and less time on the market before serious recalls…
FDA News

FDA approves Taltz for pediatric psoriasis

March 30, 2020
The FDA has approved a supplemental biologics license application for ixekizumab in pediatric patients with moderate to severe plaque psoriasis…
In the Journals

Derm residency programs lack sexual, gender minority content

March 27, 2020
Curricular integration is inconsistent for sexual and gender minority patients in dermatology residency programs, according to a research letter…
Healio Jobs